Yong‐Kek Pang

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer

Jhanelle E. Gray, Isamu Okamoto, Virote Sriuranpong et al. · Clinical Cancer Research · 2019 · 126 citations · Full text

Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301

Byoung Chul Cho, Myung‐Ju Ahn, Jin Hyoung Kang et al. · Journal of Clinical Oncology · 2023 · 122 citations · Full text

Pulmonary tuberculosis presenting as community‐acquired pneumonia

Chong Kin Liam, Yong‐Kek Pang, Shyamala Poosparajah · Respirology · 2006 · 59 citations

The Effect of 20-Minute Mindful Breathing on the Rapid Reduction of Dyspnea at Rest in Patients With Lung Diseases: A Randomized Controlled Trial

Tan Seng Beng, Chong Kin Liam, Yong‐Kek Pang et al. · Journal of Pain and Symptom Management · 2019 · 47 citations · Full text

Pulmonary Care, Ventilation, Respiratory Therapy +11

Changes in the distribution of lung cancer cell types and patient demography in a developing multiracial Asian country: Experience of a university teaching hospital

Chong Kin Liam, Yong‐Kek Pang, Chai‐Hooi Leow et al. · Lung Cancer · 2006 · 46 citations

University Teaching Hospital, Epidemiology, Cancer Epidemiology +11